Nalaganje...

The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial

BACKGROUND: Septic shock remains a significant cause of death in critically ill patients. During septic shock, some patients will retain microcirculatory disorders despite optimal hemodynamic support (i.e., fluid resuscitation, vasopressors, inotropes). Alterations in the microcirculation are a key...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Trials
Main Authors: Legrand, Matthieu, Oufella, Hafid Ait, De Backer, Daniel, Duranteau, Jacques, Leone, Marc, Levy, Bruno, Rossignol, Patrick, Vicaut, Eric, Dépret, François
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329442/
https://ncbi.nlm.nih.gov/pubmed/32611377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04549-y
Oznake: Označite
Brez oznak, prvi označite!